Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 2 10Phase 1/2 4Phase 3 2Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 3Sarcoma 1

Conditions

Nasopharyngeal Carcinoma 3Osteosarcoma 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Heavy Ion Radiotherapy × Clear all
NCT02795195 2025-08-07

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Completed
51 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02569788 2020-02-17

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Terminated
9 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02801487 2020-02-17

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 1/2 Terminated
6 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01005043 2020-01-10

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

University Hospital Heidelberg

Phase 1/2 Completed
23 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡